FindTrial
Sign In

no

Diagnostic accuracy of contrast-enhanced ultrasound-guided axillary core biopsy in preoperative staging of the newly diagnosed invasive breast cancer - a prospective study. - axillary-CEUS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-005349-20-FI
Enrollment
Unknown
Registered
2012-12-03
Start date
2013-01-15
Completion date
Unknown
Last updated
2015-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.1 Level: LLT Classification code 10006192 Term: Breast cancer NOS System Organ Class: 100000004864

Interventions

Trade Name: SonoVue Product Name: SonoVue Pharmaceutical Form: Concentrate and solvent for injection CAS Number: 2551-62-4 Other descriptive name: SULFUR HEXAFLUORIDE

Sponsors

Kuopio University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: no Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 30

Exclusion criteria

Exclusion criteria: no

Design outcomes

Primary

MeasureTime frame
Main Objective: no;Secondary Objective: no;Primary end point(s): no;Timepoint(s) of evaluation of this end point: no—

Secondary

MeasureTime frame
Secondary end point(s): no;Timepoint(s) of evaluation of this end point: no—

Countries

Finland

Contacts

Public ContactDep. of Clinical Radiology

Kuopio University Hospital

suvi.rautiainen@kuh.fi358447175816

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026